← Back to headlines
Santen Pharmaceutical Reports Q1 GAAP EPS of ¥104.99
Santen Pharmaceutical Co. announced its Q1 GAAP EPS of ¥104.99 and revenue of ¥291.62 billion.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Iran's Economy Suffers 2 Million Job Losses Amid War and Internet Blackout
just now
University of Nigeria Backs Climate Finance Research for Sustainable Development
9m ago
Nigeria Plans Housing Roadmap for Mass Home Ownership
12m ago